stockrowCumberland Pharmaceuticals Inc. (CPIX) vs Organogenesis (ORGO)
- Cumberland Pharmaceuticals Inc. CPIX 5.19 +3.59%
- Organogenesis ORGO 0.86 +2.38%
Cumberland Pharmaceuticals Inc. and Organogenesis are both Drug Manufacturers Specialty & Generic companies. Organogenesis is the larger, with a market value of $108.1M against $75.1M — 1.4× the size. Organogenesis grew revenue faster over the last twelve months: −24.3% against −25.7%. Cumberland Pharmaceuticals Inc. has the higher net margin (−34.9% vs −43.5%) and the higher return on invested capital (−34.2% vs −52.2%). Across the 20 metrics below, Cumberland Pharmaceuticals Inc. leads on 10 and Organogenesis on 10.
Valuation
Profitability
| Metric | CPIX | ORGO | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 110.49% | 65.56% | 53.51% |
| Operating margin | (23.20%) | (24.45%) | 0.00% |
| Net margin | (34.92%) | (43.50%) | (2.45%) |
| Free cash flow margin | 1.84% | 1.01% | 0.00% |
| Return on equity | (48.76%) | (81.71%) | (0.80%) |
| Return on assets | (16.70%) | (34.86%) | (1.67%) |
| Return on invested capital | (34.23%) | (52.15%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack